Global Med Technologies(R), Inc. to Announce Fourth Quarter and Year End Results on Monday, March 10, 2008
March 04 2008 - 9:00AM
PR Newswire (US)
Conference Call to Follow Release DENVER, March 4
/PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global
Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) , an
international e-Health, medical information technology company,
will report its fourth quarter and year end results on Monday,
March 10, 2008, before the market open. The Company will host a
conference call at 4:15 p.m. EDT on the same day. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
Conference Call Details: Dr. Mick Ruxin, Chief Executive Officer,
Tom Marcinek, President and Chief Operating Officer, and Darren
Craig, Vice President of Finance, will discuss the fourth quarter
and year-end results and will be available to answer questions. The
one-hour conference call will be held on Monday, March 10, 2008, at
4:15 p.m. EDT. Interested parties are welcome to call the telephone
numbers listed below five minutes prior to the start of the
conference call. Callers within the US should call: 1-866-789-9224.
Callers that are outside of the US should call: 1-706-679-9621.
Callers should reference "Global Med Technologies Fourth Quarter
Earnings Conference Call" to the conference call operator, and the
conference call ID number is: 37842682. An automated replay of the
conference call will be available from March 10, 2008 at 5:15 p.m.
(EDT) until March 12, 2008 at 11:59 p.m. (EDT). To access the
replay, please call 1-800-642-1687 if within the US. Callers that
are located outside of the US should call: 1-706-645-9291 and enter
Global Med's access code of 37842682. The replay of the conference
call will be available from March 12, 2008 onward at Global Med's
website at http://www.globalmedtech.com/. About Global Med
Technologies, Inc. Global Med Technologies(R), Inc. is an
international e-Health medical information technology company
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies(R) division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers. Each
year, Wyndgate's products and services manage more than eight
million blood components, representing over 27% of the U.S. blood
supply. Wyndgate's products are also being used in Canada, Africa,
and the Caribbean. Wyndgate's software provides Vein-to-Vein(R)
tracking from donor collection to patient transfusion through its
Donor Doc(TM) interactive donor health history questionnaire,
ElDorado Donor(TM) and SafeTrace(R) donor management systems, to
its SafeTrace Tx(R) advanced transfusion management system. Global
Med's PeopleMed(R), Inc. subsidiary provides custom software
validation, consulting and compliance solutions to hospitals and
blood centers. PeopleMed's in-depth knowledge of Wyndgate's
products and the blood banking industry results in cost-effective
validation services, which leads to more efficient software
implementations and upgrades for our customers. For more
information about Global Med's products and services, please call
800-WYNDGATE or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/ and http://www.wyndgate.com/ . This news
release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate,"
"project," "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: company, Michael I. Ruxin, M.D., of Global Med
Technologies, Inc., +1-303-238-2000, ; or investors, Paul Holm,
President of portfoliopr.inc, +1-212-999-5585, , for Global Med
Technologies, Inc. Web site: http://www.globalmedtech.com/
http://www.peoplemed.com/ http://www.wyndgate.com/
Copyright